Search PubMed⌕ Search

Biomedical subjects

L Guize

Publications and source records attributed to L Guize.

At least 91 records · Page 5Linked to original sources

Correlation between time-domain measures of heart rate variability and scatterplots in postinfarction patients.

Heart rate variability (HRV) is usually measured in time or frequency domains. Beat-to-beat variability, which cannot be assessed by frequency-domain analysis, and can only be assessed globally by time-domain analysis, provides information concerning the nonlinear behavior of heart rate. This beat-to-beat variability can be displayed on scatterplots, where each RR interval is plotted against the preceding RR interval. However, the relationship between scatterplots and other measures of HRV is unknown. We studied the correlations between time-domain measures and scatterplot length, width, and area in 50 postinfarction patients. Scatterplot length and width were measured after printing. Scatterplot area was calculated from length and width, assimilating the plot to an ellipse. Long-term variability indexes (SDNN and SDANN) were strongly correlated with scatterplot length (r > 0.9, P < 0.0001), and short-term variability parameters (pNN50 and variability index) with scatterplot width (r > 0.9; P < 0.0001). Scatterplots are, therefore, a simple way of providing information concerning long- and short-term HRV. Furthermore, measurement of scatterplot width at different given RR intervals could be an approach to the evaluation of short-term HRV for different heart rates. This could provide a simple way of assessing cardiac parasympathetic modulation at different heart rates.

Adult↗

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

Factor VII coagulant activity (FVIIc) has been found to be related to cardiovascular risk factors and may be an independent predictor of coronary heart disease (CHD). Whether these associations are due to changes in FVII activation rather than FVII concentration remain unclear. Therefore, we investigated the relationships between activated factor VII (FVIIa) and CHD risk factors in healthy subjects (336 men and 348 women) aged 25 to 64 years. In addition to direct quantitation of FVIIa by use of a recombinant, truncated tissue factor, FVIIc and factor VII antigen (FVII:Ag) levels were measured by standard procedures. There were highly significant correlations between the three techniques of FVII assay (r > + .55). Plasma FVIIc and FVIIa levels increased with age in both sexes, but the rate of rise was significantly greater in women than men. At younger ages, mean values of FVIIc and FVIIa were significantly lower in women than men, whereas at older ages the reverse was observed. After adjustment for age, postmenopausal women had significantly higher mean levels of FVIIc and FVIIa than did premenopausal women. Hormone replacement therapy significantly reversed the rise in FVIIc in postmenopausal women, and a similar trend in FVIIa was also observed. Age-, sex-, and menopause-related changes in FVIIc were partly explained by a higher proportion of fully active FVII molecules, as indicated by significant differences in the FVIIa-to-FVII:Ag ratio. Oral contraceptive use was associated with high FVIIc levels, and this effect was mainly due to an increase in FVII:Ag. Levels of FVIIa were positively correlated with serum cholesterol concentrations in both sexes. There were no strong associations between FVIIa levels and other CHD risk factors, including smoking habits, alcohol consumption, blood pressure, obesity, glucose, triglycerides, and serum lipoprotein(a) concentrations. Multiple regression analysis showed independent effects of age and cholesterol levels on FVIIa in men, whereas age and menopausal status were the main predictors of FVIIa in women. Our results show that FVII activation is associated with CHD risk factors. These findings are consistent with a possible role for FVII in the pathogenesis of CHD. Furthermore, our data suggest that the dramatic rise in CHD incidence in postmenopausal women as well as the cardioprotective effect of estrogen may be mediated through FVII and blood coagulation.

Adult↗

[Radiofrequency ablation: physical bases and principles].

Radiofrequency currents are the reference physical agent for endocavitary ablation, especially of supraventricular tachycardias. They are delivered in a continuous mode or sinusoidal waves. Because of the high frequency between 200 and 3,000 kHz there is no stimulation of the neuromuscular cells. The mechanism of the resulting lesion is essentially related to heating of the biological surroundings of the active electrode. The temperature increase remains localised around the active electrode and its kinetics are progressive, which implies close and stable contact between the active electrode and the tissues. The lesional effect is obtained 60 to 90 degrees C in order to avoid the deleterious effects induced by temperatures of over 100 degrees C: boiling, coagulation, vaporization and carbonization of the tissues leading to an increase in impedence. The volume of lesions depends on many factors which are sometimes difficult to control in vivo. It is more closely correlated to the temperature of the active electrode than to the parameters of delivery (power, duration ...). The histological lesions correspond to scar tissue which respects the surrounding architecture. The major technological innovations of this method have resulted in an increase in the volume of the lesions produced, a reduction in the frequency of undesirable effects such as the formation of coagulum and in an immediate evaluation of the anatomic lesional effect. They have consisted in the introduction of specific electrodes and of systems of monitoring the electrical and thermal effects with the use of imaging techniques such as endovascular and transoesophageal echocardiography and angioscopy. New indications will require development of specific catheter-generator equipment to create lesions of size and shape adapted to the arrhythmogenic substrate.

Animals↗

Combined effects of blood pressure and body mass index on left ventricular structure in middle-aged males: cross-sectional and 2-year longitudinal results.

OBJECTIVE: To compare the 2-year longitudinal with the cross-sectional relationships of blood pressure and body mass index with echocardiographic left ventricular measurements in middle-aged males with no history of cardiovascular disease or hypertension. METHODS: M-mode echocardiograms of adequate quality were obtained at initial and 2-year follow-up examinations in 177 subjects. Measurements of left ventricular wall thickness and internal dimensions were made, and estimates of left ventricular mass/height were calculated. Longitudinal changes in left ventricular measurements and risk factors were computed as the differences between the follow-up and initial values. RESULTS: Systolic blood pressure (SBP) was significantly associated with left ventricular mass/height and wall thickness in cross-sectional and in longitudinal analyses. Similar results were observed after adjusting for age, body mass index, sport activity and heart rate. Although body mass index was strongly related to left ventricular mass/height, wall thickness and internal dimension in the cross-sectional study, no significant associations were observed between changes in body mass index and in left ventricular measurements. CONCLUSIONS: The present study emphasizes the differential effects of spontaneous changes in blood pressure and body mass index on the evolution of the left ventricular mass in middle-aged males. Spontaneous changes in SBP during the 2-year follow-up period were associated with rapid changes in left ventricular structure. The 2-year period might not have been sufficient for body mass index to induce changes in left ventricular structure. The duration and amplitude of body weight changes which entail changes in left ventricular mass remain to be determined by further longitudinal investigations.

Blood Pressure↗

Radioisotopic pacemaker: long-term clinical results.

In order to prolong the service life of the generator, the isotopic pacemakers, powered by Pu238, have been developed and implanted since 1970. We report the follow-up of 325 patients (mean age 39 +/- 18 years) implanted with an isotopic pulse generator (Medtronic 9000/9090) between April 1970 and July 1982. The mean follow-up was 12 years (range 6 days to 18.5 years). The generator was highly reliable; the mean value of pacing rate between implantation and last follow-up decreased significantly but no more than 1 beat/min (72.7 vs 71.8 beats/min; P < 0.001) and the pulse width did not change significantly. The actuarial survival of the device was 97% at 18.5 years. During the follow-up period, 122 reoperations were performed in 85 patients: 88 explanations of the entire pacing system and 34 modifications of the lead system. Lead dysfunction accounted for 68% of the 122 reoperations, generator failure for 6%, and miscellaneous reasons for 26%. However, 72% of patients remain free of intervention during the follow-up period and 61 patients (20%) died during this period. Most deaths (52%) were of nonsudden cardiovascular origin, 17% were related to cancer, and 13% to sudden death. After 5, 10, and 18.5 years, 94%, 89%, and 73% of the patients were alive, respectively. No side effect could be attributed to the radioisotope. We conclude that this isotopic pacemaker demonstrated its reliability for long-term cardiac pacing.

Actuarial Analysis↗

[Impact of controlling risk factors after myocardial infarction].

The relative risks of each factors and the benefits of their reduction after myocardial infarction are comparable to those observed in primary prevention. However, because of an overexposure to the risk, the absolute gains are five times greater. The impact of diet is one of the most important: in addition to the limitation of polyunsaturated fats and global calory intake, especially in cases of central obesity, the increase in dietary alpha-linolenic acid and in omega-3, has been shown to reduce the risk of myocardial infarction and mortality by up to 70%. Supplements of vitamins A and E could be useful. After infarction, the risks of an ex-smoker decrease rapidly by half and become comparable to those of non-smokers in 2 to 3 years. Physical exercise reduces cardiovascular mortality by 20-25% and contributes to better control of risk factors. The management of some psycho-physiological factors (reaction to stress, hostility) also gives encouraging results). A 10% reduction in total cholesterol leads to a 20% or more decrease in coronary events and a 10% reduction in mortality with a marked dose-response effect inciting to the reduction of its level to under 2 g/l. The progression of atherosclerosis delayed; early lesions, with the greatest risk of rupture and thrombosis, are stabilised and may even regress. A low HDL-c concentration should lead to more energetic reduction of LDL-c and control of smoking, obesity and sedentarity. Its association with hypertriglyceridaemia, glucose intolerance, hypertension and central obesity defines the syndrome of insulin resistance which multiplies cardiovascular risk.(ABSTRACT TRUNCATED AT 250 WORDS)

Humans↗

[Treatment of obstructive cardiomyopathy by permanent apical ventricular stimulation].

The treatment of obstructive hypertrophic cardiomyopathy is classically based on beta blockers, cardiac calcium channel blockers or amiodarone to improve the symptoms and to decrease the intraventricular gradient. However, this treatment may prove to be insufficient or poorly tolerated. Two chamber cardiac pacing no constitutes an alternative to surgical treatment, as it improves the symptoms and decreases the left intraventricular gradient, by modifying the ventricular activation sequence. In order to be effective, ventricular pacing must be continuous, with a sufficiently short atrioventricular period to allow continuous ventricular preexcitation, while preserving atrial contraction. However, it has yet to be demonstrated that continuous ventricular pacing provides a survival benefit for these patients.

Cardiac Pacing, Artificial↗

Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.

Several studies have suggested a dose-response relation between the oestrogen content of oral contraceptive (OC) and the risk of both venous thrombosis and arterial disease, when oestrogen doses were higher than 50 micrograms. However, there is no clear epidemiological evidence for a decrease in thrombotic risk with formulations containing less than 50 micrograms oestrogen. Therefore, we investigated haemostatic variables in users of OC containing either 30 micrograms (35 women) or 50 micrograms (29 women) ethinyl estradiol as compared with non users (64 women) matched for age and smoking status. Mean values of antithrombin activity were significantly lower in 30 micrograms or 50 micrograms oestrogen users than in non users (96% and 98% vs 105%, respectively, p < 0.001), but they were not significantly different between the two groups of OC users. There was a significant increase in mean values of factor VII antigen in women taking either 30 micrograms or 50 micrograms oestrogen as compared with non users (96% and 101% vs 85%, respectively, p < 0.005). Although the difference between both groups of OC users was not significant, a positive linear trend in factor VII levels was observed within the 0-50 micrograms oestrogen range (p < 0.001). Mean levels of fibrinogen were slightly higher in 30 micrograms or 50 micrograms oestrogen users than in non users (2.71, 2.66 g/l vs 2.55 g/l, respectively), but there was no significant difference between the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

[Changes in heart rate variability after myocardial infarction. Value of Poincareé's diagram].

The variability of the heart rate is reduced after myocardial infarction. It then progressively increases, to return to near normal values after several months. However, these changes in heart rate variability occur at the same time as slowing of the heart rate which makes interpretation difficult. Poincaré's diagram is constructed from a Holter recording plotting each RR interval against the preceding RR interval. The authors have developed a geometric approach to this diagram to evaluate parasympathetic tone for a given heart rate. By measuring the dispersion in height of the Poincaré's diagram, the authors evaluate the shor-term variability for a given RR interval. Two 24 hr Holter recordings were performed in 52 patients at one and two weeks after a myocardial infarction. The dispersion in the height of the Poincaré's diagrams was measured at the 10th, 25th, 50th, 75th and 90th percentiles of the total dispersion. The authors have shown an increase in the short-term variability of the shortest RR intervals (1th, 25th and 50th percentiles) which is not observed in the longer RR intervals (75th and 90th percentiles). In conclusion, theres is an increase in the heart rate variability at the shortest RR intervals. This suggests that the recovery of parasympathic tone after myocardial infarction occurs mainly at the fastest heart rates.

Aged↗

Cardiac lymphoma presenting as atrial flutter in an AIDS patient.

An increasing number of patients with the acquired immunodeficiency syndrome (AIDS) and cardiac lymphoma have been documented. Antemortem diagnosis of cardiac non-Hodgkin lymphoma in AIDS is difficult because of the non-specificity of the clinical findings. Rapid progression of cardiac dysfunction is common after symptoms appear. We report the case of a patient with AIDS and cardiac lymphoma revealed by an atrial flutter.

Atrial Flutter↗

Single infusion of intravenous cibenzoline in the treatment of supraventricular tachyarrhythmias following heart surgery. A double-blind placebo-controlled parallel study.

The efficacy and safety of a single infusion of cibenzoline, a class I antiarrhythmic drug, were assessed in 86 patients presenting with a supraventricular tachyarrhythmia following heart surgery in a placebo-controlled double-blind parallel study. Cibenzoline was effective in 13 patients (30%) vs three patients (6.9%) with placebo (P < 0.05). In the non-converted patients, ventricular rate was significantly slowed by cibenzoline (P < 0.05), which also significantly increased the duration of QRS and QT intervals. Transient adverse events were seen in nine patients receiving cibenzoline: moderate hypotension, sweating, right bundle branch block. One patient with decreased left ventricular function had an increased ventricular rate and QRS duration associated with hypotension. There were no severe adverse events. These results suggest that cibenzoline is effective for the treatment of postoperative supraventricular tachyarrhythmias in patients without impairment of ventricular function.

Anti-Arrhythmia Agents↗

[Limitations of ventricular late potentials in atrial fibrillation].

It is generally admitted that the chaotic atrial activation in atrial fibrillation makes analysis of ventricular late potentials uninterpretable. However, some workers have contradicted this affirmation. The authors performed signal averaged electrocardiogram in 17 patients with atrial fibrillation before cardioversion for external D.C. shock. The recording was repeated 15 minutes after restoration of sinus rhythm. None of the patients had complete bundle branch block in atrial fibrillation or sinus rhythm. Analysis was made with a band pass filter of 40 Hz and to a final noise level of 0.3 microV. The positivity of late ventricular potentials was confirmed by the presence of at least 2 of the usual 3 criteria: an averaged QRS duration > 120 ms, a RMS 40 < 20 microV and a LAS > 40 ms. The mean duration of the averaged filtered QRS complex was 122 ms in atrial fibrillation and 112 ms in sinus rhythm, a non significant decrease of 9%. The mean value of the RMS 40 was 24 microV before cardioversion versus 29 microV after restoration of sinus rhythm, a significant increase of 19% (p < 0.05). Finally, the mean duration of the LAS in atrial fibrillation was 45 ms, decreasing to 35 ms in sinus rhythm, a significant reduction of 22% (p < 0.05). In atrial fibrillation, 10 patients had ventricular late potentials (2 positive criteria) and 7 had no ventricular late potentials. In sinus rhythm, on the other hand, 6 patients were positive and 11 negative.(ABSTRACT TRUNCATED AT 250 WORDS)

Action Potentials↗

[Radiofrequency catheter ablation: theoretical and technical aspects].

Radiofrequency currents produce circumscribed tissue necrosis by progressive and localised heating. Endocardial application via the percutaneous approach with a specific electrophysiological catheter enables destruction of the anatomical substrate of many cardiac arrhythmias. The technique is well tolerated due to the absence of barometric phenomena and general anaesthesia, and the possibility of modulating the energy delivered, which explains why it has supplanted fulguration in most indications. The technological evolution aims to increase the lesional power and decrease the number of complications. This implies the development of catheters capable of delivering greater currents without the risk of thrombus formation and of generators dependent on electrical or thermal parameters. The low incidence of complications reported by centres using the technique is based on an excellent understanding of the technique, the use of appropriate material, the surveillance of parameters which allow detection of unwanted effects and the respect of a strict operation protocol. In the absence of these precautions, the wide diffusion of this technique, favored by its low cost and relative simplicity, may be associated with an increase in the number of side effects which could be lethal. This cannot be accepted in a technique with such wide indications, including arrhythmias with a usually benign long-term prognosis.

Animals↗

[Mechanisms of atrial fibrillation: recent advances].

Atrial fibrillation (AF) is due to the presence of multiple reentry pathways. Although this mechanism has been known for some time, new information has recently been acquired about the factors of atrial vulnerability and the conditions of myocardial alteration. There are two main factors of atrial vulnerability: intra-atrial conduction defects and abnormalities of the refractory periods. In addition, the concept of critical mass and the influence of the autonomic nervous system have to be taken into consideration. The abnormalities of the refractory periods liable to increase atrial vulnerability are their shortening, spatial dispersion and poor adaptation to the heart rate. All these changes may be demonstrated at cellular level. The product of the intra-atrial conduction velocity and the duration of the refractory period defines the wave length. The risk of developing reentry pathways increases as the wave length shortens. Moreover, the more the atrium fibrillates, the greater will be the decrease of the refractory periods, atrial fibrillation giving rise to atrial fibrillation. Histological lesions of the atrial tissue may be demonstrated, even in the absence of underlying cardiac disease. They mainly consist of fibrosis, fatty degeneration and myocytic hypertrophy. In the long-term, atrial fibrillation leads to a number of structural abnormalities of the atrial, and sometimes ventricular tissues, progressing to cardiomyopathy in some cases.

Action Potentials↗

[Diagnosis, course and prognosis of pulmonary arterial hypertension].

Pulmonary arterial hypertension (PAHT) is defined by an increase in mean pulmonary artery pressure above 20 mmHg. Its diagnosis is often easy by cardiac echo-Doppler. Hemodynamic investigation is required in non-echogenic patients or in order to define the type of PAHT: pre- or post-capillary. It is important to determine, on the basis of non-invasive clinical and paraclinical (echocardiography) studies, those patients in whom catheterisation is indicated. PAHT may be due to chronic respiratory disease, left heart disorders, congenital heart disease or follow pulmonary embolism. It is sometimes apparently primary. The prognosis of PAHT depends upon its etiology: when PAHT is secondary to heart disease, it reflects worsening of the causative cardiac problem, which must be corrected. PAHT is a prognostic factor in chronic obstructive lung disease. The course is particularly grave in primary PAHT.

Echocardiography, Doppler↗

[Interventional cardiology methods in the treatment of ventricular arrhythmia].

Sustained ventricular arrhythmias are the primary cause of sudden death in France. Treatment possibilities have increased in recent years with the development of interventional rhythmology techniques. Thus alongside the classical pharmacological approach, clinicians now have access to more aggressive treatment methods such as implantable pacing-defibrillation systems or endocavitary excision techniques. Implantable defibrillation systems are of proven efficacy in reducing ventricular arrhythmias but their action is merely palliative. Technological advances have simplified their implantation and increased their diagnostic and therapeutic abilities. Their high price is nevertheless one of the factors limiting their wider use in some countries. Endocavitary excision techniques, with a radical curative effects, are used only in cases of sustained monomorphous ventricular tachycardia in the absence of any associated cardiac surgery procedure. Coronary angioplasty is of rhythmological value when the etiopathogenesis of the arrhythmia is of proven ischemic origin. Rather than being competitors, these various methods are complementary, each having specific characteristics forming the basis of particular indications.

Arrhythmias, Cardiac↗

Haemostatic variables and menopausal status: influence of hormone replacement therapy.

Large cohort studies have shown that postmenopausal estrogen use was associated with a reduction in the risk of coronary heart disease. This putative beneficial effect of hormone replacement therapy (HRT) may be partly mediated through changes in clotting factors and fibrinolytic system. We have measured haemostatic variables in 293 consecutive healthy women aged 45-54 years who attended a health check-up centre in Paris (IPC). Premenopausal women taking hormonal therapy were excluded (n = 34). Most women using HRT were given 17-beta estradiol in combination with progestin. Mean levels (m +/- sd) of plasma fibrinogen, factor VII coagulant activity and plasminogen activator inhibitor (PAI) were significantly higher in postmenopausal women not taking HRT (n = 99) than in premenopausal women (n = 139) within the same decade (319 +/- 52 mg/dl vs 304 +/- 60 mg/dl, 107 +/- 17% vs 96 +/- 16%, 9.73 +/- 5.71 U/ml vs 7.61 +/- 4.36 U/ml respectively). Allowance for main cardiovascular risk factors made no substantial differences to the results, although the effect of the menopause on fibrinogen was no longer significant. HRT (n = 21) significantly reversed the menopause-related changes in factor VII (94 +/- 15%), even after adjustment for confounding factors. The same trend in both fibrinogen (294 +/- 46 mg/dl) and PAI (8.22 +/- 5.51 U/ml) was observed. Similar results were found in women using oral or percutaneous estrogen. Our findings suggest that 17-beta estradiol in combination with progestins may protect against an increased thrombotic tendency in postmenopausal women. Randomized clinical trials are urgently needed for a better understanding of HRT effect on atherothrombotic process.

Coronary Disease↗